Under construction – not a live service
Sign in
Taking people in ChinaPhase 2/3

ICP-332 in Subjects With Non-segmental Vitiligo

Key facts

Where
Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Hengyang, Jinan, Jingzhou, Kunming, Lianyungang, Luoyang, Nanchang, Nanjing, Nanyang, Ningbo, Shanghai, Shenyang, Shijiazhuang, Shiyan, Suzhou, Weihui, Wenzhou, Wuhan, Wuhu, Xian, Yiwu, Zhengzhou, and Zibo, ChinaSee the 45 sites
Phase
Phase 2/3

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 12 and 75 years old?

Source: NCT07047612, who can take part

Where in China

  • Beijing Chao-Yang Hospital, Capital Medical UniversityBeijing, ChinaContact: Fang LiuNot yet recruiting
  • Beijing Tongren HospitalBeijing, ChinaContact: Aihua WeiNot yet recruiting
  • Peking University Third HospitalBeijing, ChinaContact: Chunlei ZhangNot yet recruiting
  • The first hospital of Jilin UnivercityChangchun, ChinaContact: Shanshan LiNot yet recruiting
  • The Second Xiangya Hospital of Central South UniversityChangsha, ChinaContact: Yunsheng LiangNot yet recruiting
  • Xiangya Hospital of Central South UniversityChangsha, ChinaContact: Juan LiNot yet recruiting
  • Chengdu Second People's HospitalChengdu, ChinaContact: Yanping FengNot yet recruiting
  • Sichuan Provincial People's HospitalChengdu, ChinaContact: Lixia ZhangNot yet recruiting
  • Chongqing Traditional Chinese Medicine HospitalChongqing, ChinaContact: Qingchun 400000 DiaoTaking people
  • The First Affiliated Hospital of Chongqing Medical UniversityChongqing, ChinaContact: Bin WeiNot yet recruiting
  • The First Affiliated Hospital of Fujian MedicalFuzhou, ChinaContact: Niu XiangNot yet recruiting
  • Union Hospital affiliated to Fujian MedicalFuzhou, ChinaContact: Huichun SuNot yet recruiting
  • Deramatology Hospital of Southern Medical UnivercityGuangzhou, ChinaContact: Xiaowei ShiNot yet recruiting
  • Nanfang HospitalGuangzhou, ChinaContact: Yue ZhengNot yet recruiting
  • Sun Yat-sen Memorial Hospital, Sun Yat-sen UniversityGuangzhou, ChinaContact: Liangchun WangNot yet recruiting
  • Affiliated Hangzhou First People's Hospital,School of Medicine,Westlake UniversityHangzhou, ChinaContact: Liming WuNot yet recruiting
  • Hangzhou Third People's HospitalHangzhou, ChinaContact: Aie XuTaking people
  • The First Affiliated Hospital of University of South ChinaHengyang, ChinaContact: Zhijun LiuNot yet recruiting
  • Qilu Hospital of Shandong UniversityJinan, ChinaContact: Yin LiTaking people
  • Shandong First Medical University Affiliated Dermatology Hospital (Shandong Institute of Dermatology and Venereology, Shandong Dermatology Hospital)Jinan, ChinaContact: Furen ZhangNot yet recruiting
  • Jingzhou Central HospitalJingzhou, ChinaContact: Yi SunNot yet recruiting
  • The First Affiliated Hospital of Kunming Medical UniversityKunming, ChinaContact: Dongjie SunNot yet recruiting
  • The First People's Hospital of LianyungangLianyungang, ChinaContact: Hong RenNot yet recruiting
  • The Second Affiliated Hospital of Henan University of Science and TechnologyLuoyang, ChinaContact: Bin ZhangNot yet recruiting
  • Dermatology Hospital of Jiangxi ProvinceNanchang, ChinaContact: Xiaoyi WenNot yet recruiting
  • The First Affiliated Hospital of NanChang UniversityNanchang, ChinaContact: Xianwei CaoNot yet recruiting
  • Hospital for Skin Diseases, Chinese Academy of Medical SciencesNanjing, ChinaContact: Qianjin LuNot yet recruiting
  • Nanyang First People's HospitalNanyang, ChinaContact: Rixin ChenNot yet recruiting
  • The First Affiliated Hospital of Ningbo UniversityNingbo, ChinaContact: Bingjiang LinNot yet recruiting
  • Huashan Hospital, Fudan UniversityShanghai, ChinaContact: Folra XiangTaking people
  • Shanghai Dermatology HospitalShanghai, ChinaContact: Yangfeng DingNot yet recruiting
  • Shenyang Medical College Affiliated Central HospitalShenyang, ChinaContact: Xiaodong LiNot yet recruiting
  • The Second Hospital of Hebei Medical UniversityShijiazhuang, ChinaContact: Yanling LiNot yet recruiting
  • Shiyan People's HospitalShiyan, ChinaContact: Zudong MengNot yet recruiting
  • Suzhou Municipal HospitalSuzhou, ChinaContact: Jun GuNot yet recruiting
  • The First Affiliated Hospital of Xinxiang Medical CollegeWeihui, ChinaContact: Dandan FuNot yet recruiting
  • The First Affiliated Hospital of Wenzhou Medical UniversityWenzhou, ChinaContact: Zhiming LiNot yet recruiting
  • Wuhan NO.1 Hospital(Wuhan Hospital of Traditional Chinese and Western Medicine)Wuhan, ChinaContact: Liuqing ChenNot yet recruiting
  • The First Affiliated Hospital of Wannan Medical CollegeWuhu, ChinaContact: Chao CiNot yet recruiting
  • the Second Affiliated Hospital of Wannan Medical CollegeWuhu, ChinaContact: Ruzhi ZhangNot yet recruiting
  • Shaanxi Provincial People's HospitalXian, ChinaContact: Li YangNot yet recruiting
  • The Fourth Affiliated Hospital, Zhejiang University School of MedicineYiwu, ChinaContact: Lunfei LiuNot yet recruiting
  • Henan Provincial People's HospitalZhengzhou, ChinaContact: Jianguo LiNot yet recruiting
  • Zhengzhou Central Hospital Affiliated to Zhengzhou UniversityZhengzhou, ChinaContact: Zixue ChenNot yet recruiting
  • Zibo Central hospitalZibo, ChinaContact: Guowei ZhaoNot yet recruiting

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Beijing InnoCare Pharma Tech Co., Ltd.
Trial code
NCT07047612
Record updated
7 August 2025
Original description
This a phase II/III randomized, double-blind, placebo-controlled, parallel group, adaptive design, multi-center study to evaluate the efficacy and safety of ICP-332 in subjects with non-segmental vitiligo。The study consisted an phase 2 part and an phase 3 part.Read full original descriptionShow less

A Phase II/III Randomized, Double-blind, Placebo-controlled, Parallel Group, Adaptive Design, Multi-center Study to Evaluate the Efficacy and Safety of ICP-332 in Subjects With Non-segmental Vitiligo

This a phase II/III randomized, double-blind, placebo-controlled, parallel group, adaptive design, multi-center study to evaluate the efficacy and safety of ICP-332 in subjects with non-segmental vitiligo。The study consisted an phase 2 part and an phase 3 part.

Inclusion: Male or female subjects aged ≥18 years and ≤75 years (Phase II portion). Male or female subjects ≥12 years of age and ≤75 years of age, adolescent subjects must weigh ≥40 kg (Phase III portion); Eligible subjects must meet all of the following criteria at screening and baseline:; The clinical diagnosis was non-segmental vitiligo for at least 3 months; Involvement of BSA≥5%; Facial involvement BSA≥0.5%; F-VASI≥0.5 and T-VASI between 5 and 50; Active or stable non-segmental vitiligo was present at both screening and baseline visits; Women of childbearing potential (WOCBP) and Men must agree to contraception; Before beginning any screening or study specific procedures, subjects must voluntarily sign informed consent.

Exclusion: Any of the following vitiligo related medical conditions and other skin diseases/conditions; Subjects had other types of vitiligo (including but not limited to segmental vitiligo and mixed vitiligo) that did not meet the criteria for active or stable vitiligo described in Inclusion criteria 2; History of any clinically major diseases, with the exception of vitiligo; Pregnant or breastfeeding females; The investigator considers that the subject is not suitable for participation in this study for any reason.

ClinicalTrials.gov NCT07047612